Kala Bio director Purdy reports no share ownership

KALA BIO director Brendan P. Purdy filed an initial ownership report stating he currently holds no company securities.

Rhea-AI Filing Summary

KALA BIO director Brendan P. Purdy filed an initial ownership report stating he currently holds no company securities. The Form 3 identifies him as a director of KALA BIO, Inc. and confirms that no non-derivative or derivative securities are beneficially owned as of the reported event date.

The filing also notes that a power of attorney authorizes Avraham Minkowitz to sign and submit the report on Purdy’s behalf.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the KALA BIO (KALA) Form 3 filed for Brendan P. Purdy show?

The Form 3 for KALA BIO director Brendan P. Purdy reports that he beneficially owns no KALA BIO securities. It is an initial statement of ownership, confirming zero holdings in both non-derivative and derivative securities at the time of the reported event.

What is Brendan P. Purdy’s role at KALA BIO (KALA) in this Form 3?

The Form 3 identifies Brendan P. Purdy as a director of KALA BIO, Inc. It does not list him as an officer or 10% owner, and it indicates no other reported relationship categories beyond the director role at the company.

Does the KALA BIO (KALA) Form 3 report any shares or options owned by Brendan P. Purdy?

No, the Form 3 explicitly states that no securities are beneficially owned by Brendan P. Purdy. Both the non-derivative and derivative securities tables contain no reported holdings, indicating zero shares or options attributable to him in this filing.

Who signed the KALA BIO (KALA) Form 3 for Brendan P. Purdy?

The Form 3 was signed by Avraham Minkowitz as attorney-in-fact for Brendan P. Purdy. A power of attorney authorizing Minkowitz to sign and file the document on Purdy’s behalf is attached as Exhibit 24 to the filing.

What is the event date reported in Brendan P. Purdy’s KALA BIO (KALA) Form 3?

The Form 3 lists an event date of 01/30/2026 for Brendan P. Purdy. This date reflects when the reportable status or relationship requiring the ownership statement arose, such as his status as a director of KALA BIO, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 04:16 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Purdy Brendan P.

(Last) (First) (Middle)

1167 MASSACHUSETTS AVENUE

(Street)

ARLINGTON MA 02476

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2026

3. Issuer Name and Ticker or Trading Symbol
KALA BIO, Inc. [ KALA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The Power of Attorney, executed by the Reporting Person, authorizing Avraham Minkowitz to sign and file this Form 3 on the Reporting Person's behalf is attached hereto as Exhibit 24.

No securities are beneficially owned.

	/s/ Avraham Minkowitz, Attorney-in-Fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.